Tokyo Tape
Sign in
← Takeda Pharmaceutical

Annual report

4502.TEDINET S100YB5L
Period2025-04-01 → 2026-03-31
Filed2026-06-17
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed
Key figures · 157
MetricValuePeriodScopeSource row
Revenue¥4.51T2025-04-01 → 2026-03-31Cons.Revenue IFRS
Revenue¥4.58T2024-04-01 → 2025-03-31Cons.Revenue IFRS
Revenue¥4.26T2023-04-01 → 2024-03-31vCons.Revenue IFRS (5-year summary)
Revenue¥4.03T2022-04-01 → 2023-03-31vCons.Revenue IFRS (5-year summary)
Revenue¥3.57T2021-04-01 → 2022-03-31vCons.Revenue IFRS (5-year summary)
Operating income¥6.2bn2025-04-01 → 2026-03-31Cons.Operating profit loss IFRS
Operating income¥342.6bn2024-04-01 → 2025-03-31Cons.Operating profit loss IFRS
Profit before tax−¥142.4bn2025-04-01 → 2026-03-31Cons.Profit loss before tax IFRS
Profit before tax¥175.1bn2024-04-01 → 2025-03-31Cons.Profit loss before tax IFRS
Profit before tax¥52.8bn2023-04-01 → 2024-03-31vCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥375.1bn2022-04-01 → 2023-03-31vCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥302.6bn2021-04-01 → 2022-03-31vCons.Profit loss before tax IFRS (5-year summary)
Net income (owners)−¥152.4bn2025-04-01 → 2026-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥107.9bn2024-04-01 → 2025-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥144.1bn2023-04-01 → 2024-03-31vCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥317.0bn2022-04-01 → 2023-03-31vCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥230.1bn2021-04-01 → 2022-03-31vCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income−¥152.1bn2025-04-01 → 2026-03-31Cons.Profit loss IFRS
Net income¥108.1bn2024-04-01 → 2025-03-31Cons.Profit loss IFRS
Net income¥144.2bn2023-04-01 → 2024-03-31vCons.Profit loss IFRS (5-year summary)
Net income¥317.0bn2022-04-01 → 2023-03-31vCons.Profit loss IFRS (5-year summary)
Net income¥230.2bn2021-04-01 → 2022-03-31vCons.Profit loss IFRS (5-year summary)
Total assets¥15.51Tat 2026-03-31Cons.Assets IFRS
Total assets¥14.25Tat 2025-03-31Cons.Assets IFRS
Total assets¥15.11Tat 2024-03-31vCons.Total assets IFRS (5-year summary)
Total assets¥13.96Tat 2023-03-31vCons.Total assets IFRS (5-year summary)
Total assets¥13.18Tat 2022-03-31vCons.Total assets IFRS (5-year summary)
Total liabilities¥8.08Tat 2026-03-31Cons.Liabilities IFRS
Total liabilities¥7.31Tat 2025-03-31Cons.Liabilities IFRS
Net assets / equity¥7.43Tat 2026-03-31Cons.Equity IFRS
Net assets / equity¥6.94Tat 2025-03-31Cons.Equity IFRS
Net assets / equity¥7.27Tat 2024-03-31vCons.Equity IFRS
Equity (owners)¥7.43Tat 2026-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥6.94Tat 2025-03-31Cons.Equity attributable to owners of parent IFRS
Cash & equivalents¥595.1bnat 2026-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥385.1bnat 2025-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥457.8bnat 2024-03-31vCons.Cash and cash equivalents IFRS
Cash & equivalents¥533.5bnat 2023-03-31vCons.Cash and cash equivalents IFRS (5-year summary)
Cash & equivalents¥849.7bnat 2022-03-31vCons.Cash and cash equivalents IFRS (5-year summary)
Operating cash flow¥1.04T2025-04-01 → 2026-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥1.06T2024-04-01 → 2025-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥716.3bn2023-04-01 → 2024-03-31vCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥977.2bn2022-04-01 → 2023-03-31vCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥1.12T2021-04-01 → 2022-03-31vCons.Cash flows from used in operating activities IFRS (5-year summary)
Investing cash flow−¥369.1bn2025-04-01 → 2026-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥367.1bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥463.9bn2023-04-01 → 2024-03-31vCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥607.1bn2022-04-01 → 2023-03-31vCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥198.1bn2021-04-01 → 2022-03-31vCons.Cash flows from used in investing activities IFRS (5-year summary)
Financing cash flow−¥496.8bn2025-04-01 → 2026-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥751.4bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥354.4bn2023-04-01 → 2024-03-31vCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥709.1bn2022-04-01 → 2023-03-31vCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥1.07T2021-04-01 → 2022-03-31vCons.Cash flows from used in financing activities IFRS (5-year summary)
EPS (basic)¥-96.752025-04-01 → 2026-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥68.362024-04-01 → 2025-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥92.092023-04-01 → 2024-03-31vCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥204.292022-04-01 → 2023-03-31vCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥147.142021-04-01 → 2022-03-31vCons.Basic earnings loss per share IFRS (5-year summary)
EPS (diluted)¥-96.752025-04-01 → 2026-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥67.232024-04-01 → 2025-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥91.162023-04-01 → 2024-03-31vCons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥201.942022-04-01 → 2023-03-31vCons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥145.872021-04-01 → 2022-03-31vCons.Diluted earnings loss per share IFRS (5-year summary)
Net assets per share¥4,702.66at 2026-03-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥4,407.01at 2025-03-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥4,635.56at 2024-03-31vCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥4,087.49at 2023-03-31vCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥3,665.61at 2022-03-31vCons.Equity to asset ratio IFRS (5-year summary)
Equity ratio47.9%at 2026-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio48.7%at 2025-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio48.1%at 2024-03-31vCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio45.5%at 2023-03-31vCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio43.1%at 2022-03-31vCons.Ratio of owners equity to gross assets IFRS (5-year summary)
ROE-2.1%2025-04-01 → 2026-03-31Cons.Rate of return on equity IFRS (5-year summary)
ROE1.5%2024-04-01 → 2025-03-31Cons.Rate of return on equity IFRS (5-year summary)
ROE2.1%2023-04-01 → 2024-03-31vCons.Rate of return on equity IFRS (5-year summary)
ROE5.3%2022-04-01 → 2023-03-31vCons.Rate of return on equity IFRS (5-year summary)
ROE4.2%2021-04-01 → 2022-03-31vCons.Rate of return on equity IFRS (5-year summary)
Employees47,029at 2026-03-31Cons.Number of employees
Employees47,455at 2025-03-31Cons.Number of employees
Employees49,281at 2024-03-31vCons.Number of employees
Employees49,095at 2023-03-31vCons.Number of employees
Employees47,347at 2022-03-31vCons.Number of employees
Revenue¥591.6bn2025-04-01 → 2026-03-31StandaloneNet sales
Revenue¥580.4bn2024-04-01 → 2025-03-31StandaloneNet sales
Revenue¥595.6bn2023-04-01 → 2024-03-31vStandaloneNet sales (5-year summary)
Revenue¥632.1bn2022-04-01 → 2023-03-31vStandaloneNet sales (5-year summary)
Revenue¥764.3bn2021-04-01 → 2022-03-31vStandaloneNet sales (5-year summary)
Operating income¥21.1bn2025-04-01 → 2026-03-31StandaloneOperating income
Operating income¥36.9bn2024-04-01 → 2025-03-31StandaloneOperating income
Ordinary income¥205.5bn2025-04-01 → 2026-03-31StandaloneOrdinary income
Ordinary income¥86.6bn2024-04-01 → 2025-03-31StandaloneOrdinary income
Ordinary income¥286.4bn2023-04-01 → 2024-03-31vStandaloneOrdinary income loss (5-year summary)
Ordinary income¥340.1bn2022-04-01 → 2023-03-31vStandaloneOrdinary income loss (5-year summary)
Ordinary income¥550.9bn2021-04-01 → 2022-03-31vStandaloneOrdinary income loss (5-year summary)
Profit before tax¥187.0bn2025-04-01 → 2026-03-31StandaloneIncome before income taxes
Profit before tax¥199.3bn2024-04-01 → 2025-03-31StandaloneIncome before income taxes
Net income¥197.3bn2025-04-01 → 2026-03-31StandaloneProfit loss
Net income¥152.8bn2024-04-01 → 2025-03-31StandaloneProfit loss
Net income¥338.9bn2023-04-01 → 2024-03-31vStandaloneNet income loss (5-year summary)
Net income¥330.6bn2022-04-01 → 2023-03-31vStandaloneNet income loss (5-year summary)
Net income¥324.4bn2021-04-01 → 2022-03-31vStandaloneNet income loss (5-year summary)
Total assets¥9.64Tat 2026-03-31StandaloneAssets
Total assets¥9.49Tat 2025-03-31StandaloneAssets
Total assets¥9.76Tat 2024-03-31vStandaloneTotal assets (5-year summary)
Total assets¥9.41Tat 2023-03-31vStandaloneTotal assets (5-year summary)
Total assets¥9.64Tat 2022-03-31vStandaloneTotal assets (5-year summary)
Total liabilities¥5.88Tat 2026-03-31StandaloneLiabilities
Total liabilities¥5.50Tat 2025-03-31StandaloneLiabilities
Net assets / equity¥3.76Tat 2026-03-31StandaloneNet assets
Net assets / equity¥3.99Tat 2025-03-31StandaloneNet assets
Net assets / equity¥4.09Tat 2024-03-31vStandaloneNet assets
Net assets / equity¥4.21Tat 2023-03-31vStandaloneNet assets (5-year summary)
Net assets / equity¥4.29Tat 2022-03-31vStandaloneNet assets (5-year summary)
Cash and deposits¥73.9bnat 2026-03-31StandaloneCash and deposits
Cash and deposits¥169.6bnat 2025-03-31StandaloneCash and deposits
EPS (basic)¥125.292025-04-01 → 2026-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥96.792024-04-01 → 2025-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥216.62023-04-01 → 2024-03-31vStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥213.062022-04-01 → 2023-03-31vStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥207.52021-04-01 → 2022-03-31vStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥125.262025-04-01 → 2026-03-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥96.782024-04-01 → 2025-03-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥216.562023-04-01 → 2024-03-31vStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥213.052022-04-01 → 2023-03-31vStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥207.52021-04-01 → 2022-03-31vStandaloneDiluted earnings per share (5-year summary)
Dividend per share¥2002025-04-01 → 2026-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥1962024-04-01 → 2025-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥1882023-04-01 → 2024-03-31vStandaloneDividend paid per share (5-year summary)
Dividend per share¥1802022-04-01 → 2023-03-31vStandaloneDividend paid per share (5-year summary)
Dividend per share¥1802021-04-01 → 2022-03-31vStandaloneDividend paid per share (5-year summary)
Net assets per share¥2,378.68at 2026-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥2,534.39at 2025-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥2,604.87at 2024-03-31vStandaloneNet assets per share (5-year summary)
Net assets per share¥2,704.87at 2023-03-31vStandaloneNet assets per share (5-year summary)
Net assets per share¥2,769.31at 2022-03-31vStandaloneNet assets per share (5-year summary)
Equity ratio39.0%at 2026-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio42.0%at 2025-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio41.9%at 2024-03-31vStandaloneEquity to asset ratio (5-year summary)
Equity ratio44.7%at 2023-03-31vStandaloneEquity to asset ratio (5-year summary)
Equity ratio44.5%at 2022-03-31vStandaloneEquity to asset ratio (5-year summary)
ROE5.1%2025-04-01 → 2026-03-31StandaloneRate of return on equity (5-year summary)
ROE3.8%2024-04-01 → 2025-03-31StandaloneRate of return on equity (5-year summary)
ROE8.2%2023-04-01 → 2024-03-31vStandaloneRate of return on equity (5-year summary)
ROE7.8%2022-04-01 → 2023-03-31vStandaloneRate of return on equity (5-year summary)
ROE7.4%2021-04-01 → 2022-03-31vStandaloneRate of return on equity (5-year summary)
Shares issued1,591,229,000at 2026-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued1,590,950,000at 2025-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued1,582,419,000at 2024-03-31vStandaloneTotal number of issued shares (5-year summary)
Shares issued1,582,296,000at 2023-03-31vStandaloneTotal number of issued shares (5-year summary)
Shares issued1,582,253,000at 2022-03-31vStandaloneTotal number of issued shares (5-year summary)
Employees4,792at 2026-03-31StandaloneNumber of employees
Employees4,808at 2025-03-31StandaloneNumber of employees
Employees5,474at 2024-03-31vStandaloneNumber of employees
Employees5,486at 2023-03-31vStandaloneNumber of employees
Employees5,149at 2022-03-31vStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 2
SegmentItemPeriodValue
Pharmaceutical Businessreportable segmentemployeesat 2026-03-3147029 pure
Pharmaceutical Businessreportable segmentemployeesat 2026-03-314792 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,774
ItemContextValueUnit
Name major shareholdersCurrentYearInstant_No2MajorShareholdersMember
Original text (Japanese)株式会社日本カストディ銀行（信託口）
Address major shareholdersCurrentYearInstant_No2MajorShareholdersMember
Original text (Japanese)東京都中央区晴海１丁目８－１２
Name major shareholdersCurrentYearInstant_No3MajorShareholdersMemberText · Plus
Address major shareholdersCurrentYearInstant_No3MajorShareholdersMemberText · Plus
Name major shareholdersCurrentYearInstant_No4MajorShareholdersMemberText · Plus
Address major shareholdersCurrentYearInstant_No4MajorShareholdersMemberText · Plus
Name major shareholdersCurrentYearInstant_No5MajorShareholdersMemberText · Plus
Address major shareholdersCurrentYearInstant_No5MajorShareholdersMemberText · Plus
Name major shareholdersCurrentYearInstant_No6MajorShareholdersMember
Original text (Japanese)JP MORGAN CHASE BANK 385642（常任代理人 株式会社みずほ銀行決済営業部）
Address major shareholdersCurrentYearInstant_No6MajorShareholdersMemberText · Plus
Name major shareholdersCurrentYearInstant_No7MajorShareholdersMember
Original text (Japanese)JP MORGAN CHASE BANK 385781（常任代理人 株式会社みずほ銀行決済営業部）
Address major shareholdersCurrentYearInstant_No7MajorShareholdersMemberText · Plus
Name major shareholdersCurrentYearInstant_No8MajorShareholdersMember
Original text (Japanese)SMBC日興証券株式会社
Address major shareholdersCurrentYearInstant_No8MajorShareholdersMember
Original text (Japanese)東京都千代田区丸の内３丁目３番１号
Name major shareholdersCurrentYearInstant_No9MajorShareholdersMember
Original text (Japanese)JPモルガン証券株式会社
Address major shareholdersCurrentYearInstant_No9MajorShareholdersMember
Original text (Japanese)東京都千代田区丸の内２丁目７－３
Name major shareholdersCurrentYearInstant_No10MajorShareholdersMember
Original text (Japanese)バークレイズ証券株式会社
Address major shareholdersCurrentYearInstant_No10MajorShareholdersMember
Original text (Japanese)東京都港区六本木６丁目１０－１
Issued shares voting rights (text)FilingDateInstantText · Plus
Description issued shares voting rightsCurrentYearInstant_SharesWithNoVotingRightsMember－
Description issued shares voting rightsCurrentYearInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember－
Description issued shares voting rightsCurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember－
Description issued shares voting rightsCurrentYearInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember－
Description issued shares voting rightsCurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember－
Description issued shares voting rightsCurrentYearInstant_OrdinarySharesSharesLessThanOneUnitMember
Original text (Japanese)１単元(100株)未満の株式
Treasury shares etc (text)FilingDateInstantText · Plus
Name of shareholder treasury shares etcCurrentYearInstant_Row1Member
Original text (Japanese)武田薬品工業株式会社
Address of shareholder treasury shares etcCurrentYearInstant_Row1Member
Original text (Japanese)大阪市中央区道修町４丁目１－１
Share ownership plans for directors and other officers and employees (text)FilingDateInstantText · Plus
Classes of shares etc (text)FilingDateInstantText · Plus
Acquisitions by resolution of shareholders meeting (text)FilingDateInstantText · Plus
Acquisitions by resolution of board of directors meeting (text)FilingDateInstantText · Plus
Acquisitions not based on resolution of shareholders meeting or board of directors meeting (text)FilingDateInstantText · Plus
Disposals or holding of acquired treasury shares (text)FilingDateInstantText · Plus
Dividend policy (text)FilingDateInstantText · Plus
Overview of corporate governance (text)FilingDateInstantText · Plus
Corporate governance company with audit and supervisory committee (text)FilingDateInstantText · Plus
Information about officers (text)FilingDateInstantText · Plus
Official title or position information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E00919-000ChristopheWeberMember
Original text (Japanese)代表取締役社長チーフ エグゼクティブ オフィサー
Name information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E00919-000ChristopheWeberMember
Original text (Japanese)クリストフウェバー(Christophe Weber)
Date of birth information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E00919-000ChristopheWeberMember1966-11-14
Career summary information about directors and corporate auditors (text)FilingDateInstant_jpcrp030000-asr_E00919-000ChristopheWeberMemberText · Plus
Term of office information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E00919-000ChristopheWeberMember
Original text (Japanese)注５
Official title or position information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E00919-000FurutaMilanoMember
Original text (Japanese)取締役チーフフィナンシャル オフィサー
Name information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E00919-000FurutaMilanoMember
Original text (Japanese)古田未来乃
Date of birth information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E00919-000FurutaMilanoMember1978-02-26
Career summary information about directors and corporate auditors (text)FilingDateInstant_jpcrp030000-asr_E00919-000FurutaMilanoMemberText · Plus
Term of office information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E00919-000FurutaMilanoMember
Original text (Japanese)注５
Official title or position information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E00919-000AndrewPlumpMember
Original text (Japanese)取締役リサーチ＆デベロップメント プレジデント
Name information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E00919-000AndrewPlumpMember
Original text (Japanese)アンドリュープランプ(Andrew Plump)

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 21 of 21 passed
balance sheet identityconsolidated 2025-03-31pass
balance sheet identityconsolidated 2026-03-31pass rounding
balance sheet identitynon_consolidated 2025-03-31pass
balance sheet identitynon_consolidated 2026-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2024-03-31pass
statement vs summary · net assetsnon_consolidated 2025-03-31pass
statement vs summary · net assetsnon_consolidated 2026-03-31pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2025-03-31pass
statement vs summary · net income attributable to parentconsolidated 2025-04-01/2026-03-31pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2025-03-31pass
statement vs summary · operating cash flowconsolidated 2025-04-01/2026-03-31pass
statement vs summary · revenueconsolidated 2024-04-01/2025-03-31pass
statement vs summary · revenueconsolidated 2025-04-01/2026-03-31pass
statement vs summary · revenuenon_consolidated 2024-04-01/2025-03-31pass
statement vs summary · revenuenon_consolidated 2025-04-01/2026-03-31pass
statement vs summary · total assetsconsolidated 2025-03-31pass
statement vs summary · total assetsconsolidated 2026-03-31pass
statement vs summary · total assetsnon_consolidated 2025-03-31pass
statement vs summary · total assetsnon_consolidated 2026-03-31pass